28Aug 2022
A randomised, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women

A randomised, double‐blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women

The study investigated glucose regulation and secretion of glucoregulatory hormones in young people with and without moxifloxacin, a drug known to block the Kv11.1 channel. Thirty‐eight participants completed the study. In young men and women, moxifloxacin, a drug known to block the Kv11.1 channel, increased QT interval, decreased glucose levels, increased muscle insulin sensitivity and more frequent episodes of hypoglycaemia.

  • #endo-diabetology

Like

Save

Share